LIXTE BIOTECHNOLOGY HOLDINGS, INC. 4
4 · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Jun 7, 2016
Insider Transaction Report
Form 4
Forman Stephen J.
Director
Transactions
- Award
Stock Option
2016-05-13+200,000→ 200,000 totalExercise: $0.16Exp: 2021-05-13→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The option vests as to 100,000 shares on May 13, 2016 and 100,000 shares on May 13, 2017.